Company Research Report: Leerink Partners

Company Overview

• Name: Leerink Partners

• Mission of the Company: Leerink Partners aims to be an indispensable partner by providing innovative advisory solutions, capital raising expertise, and unique insights to healthcare companies and their investors.

• Founded By: No information is available on the founders.

• Key People in the Company:

• Jeffrey A. Leerink, Chairman and Chief Executive Officer

• Dan Dubin, M.D., Vice Chairman, Co-President, Global Co-Head of Investment Banking

• Tom Davidson, Vice Chairman, Co-President, Global Co-Head of Investment Banking

• Barry Blake, Global Co-Head of Investment Banking

• Joseph Gentile, Chief Administrative Officer

• Steven Heineman, Senior Managing Director, General Counsel

• Rahul Chaudhary, Senior Managing Director, Head of Equity Capital Markets

• Jim Kelly, Senior Managing Director, Director of Research

• Robert Leerink, Senior Managing Director, Head of Institutional Equities

• Maura Polak, Managing Director, Human Resources

• Diane Vieira, Managing Director, Head of Marketing & Communications

• Headquarters: Boston, with additional offices in New York, San Francisco, Charlotte, Nashville, Los Angeles, Chicago, and Miami.

• Number of Employees: No information is available.

• Revenue of the Company: Leerink Partners is on track to double its revenue from pre-management buyout levels, indicating strong top-line growth in 2024. Exact figures are not available.

• Known For: Leerink Partners is known for being a highly specialized healthcare investment bank with a deep understanding of the healthcare sector, offering advisory solutions and capital markets services.

Products and Services

Leerink Partners focuses on the following sectors:

• Biopharma: Collaborating with innovators from growth-stage biotech to large-cap pharmaceuticals.

• Digital Health & Health Technology: Working with companies using digital channels and new technologies to improve clinical outcomes and reduce costs.

• Healthcare Services: Partnering with the nation's largest payers and providers to guide them through financial, technological, and regulatory changes.

• Medical Technology: Providing strategic and capital market solutions for MedTech clients.

• Tools & Diagnostics: Driving advancements across the diagnostics and tools sector.

Key service offerings include:

• M&A Advisory: Expert advice and discerning judgment to guide mergers and acquisitions.

• Capital Markets: Insights, networks, and deal expertise to facilitate capital raising.

• Private Capital Markets: Alternate financing solutions tailored to individual client needs.

• Equity Research: Providing deep healthcare coverage and industry insights.

• Institutional Equities: Specialized connectivity to institutional investors.

• Corporate Access: Facilitating exclusive relationship-building opportunities.

Recent Developments

• Strategic Hires:

• Addition of Holden Hodgson as Senior Managing Director, Derivatives.

• Grant Curry and Jason Truman joined the biopharma M&A team as Senior Managing Directors.

• Tom Davidson joined as Co-President and Co-Head of Global Investment Banking.

• Corporate Expansion:

• Expansion in the Healthcare Medical Technology, Life Science Tools, and Diagnostics Team with industry veterans Dr. Bernhard Sakmann and Justin Reed.

• New Initiatives:

• Launch of the Center for Pharmacoeconomics by Leerink Partners’ affiliate, MEDACorp, focusing on evaluating the societal impact of healthcare treatments.

• Recent Transactions:

• Sale advisories for transactions including Knipper Health to Frazier Healthcare Partners and bluebird bio sale to Carlyle and SK Capital Partners.

With the continued evolution of global markets, Leerink Partners aims to strengthen its position by delivering innovative solutions that create long-term value for clients and partners. Each new hire and initiative reflects the firm's commitment to excellence and its mission to be an indispensable partner in the healthcare investment landscape.